News Articles
Browse our entire archive of news articles, spotlight interviews, and other editorial pieces in one place.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Filters
Tag
Ketamine One Highlights Psychedelic Research And Announces New Clinical Trial
Wellbeing Digital Sciences
Numinus
Psyched Wellness
Braxia Scientific to Present at the Psychedelics in Psychiatry and Beyond Virtual Conference Hosted by H.C. Wainwright & Co. on June 17, 2021
Braxia Scientific Corp.
Core One Labs Plans Share Consolidation in Preparation of Listing its Common Shares on Nasdaq
Core One Labs Inc.
Mydecine Unveils Artificial Intelligence Drug Discovery Program
Mydecine Innovations Group
Ketamine One Closes Previously Announced Acquisition Of Integrated Rehab And Performance
Wellbeing Digital Sciences
BetterLife Pharma to Present at the H.C. Wainwright Psychedelics in Psychiatry and Beyond Virtual Conference on June 17th
BetterLife Pharma
PharmaTher Files FDA Pre-IND Meeting Request and Briefing Package For KETABET™ To Treat Depression
Pharmather
Field Trip Health Ltd. Announces Completion of DMPK Studies, Engineering Batch for FT-104, Its Novel Psychedelic Compound
Field Trip Health
Revive To Present at the H.C. Wainwright Psychedelics in Psychiatry and Beyond Virtual Conference
Revive Therapeutics
Ketamine One Appoints Loreto Grimaldi to Board of Directors
Wellbeing Digital Sciences
NeonMind to Present at H.C. Wainwright Psychedelics in Psychiatry and Beyond Virtual Conference
NeonMind Biosciences Inc.
Core One Labs’ Biosynthesized Psilocybin Provisional Patent Imminent
Core One Labs Inc.
Creso Pharma completes US OTC dual listing
Creso Pharma
Get the Headlines & Market Updates
Be the first to see new company features, exclusive interviews and breaking news. Subscribe now.